Cyanide

Cyanide

SCHEMBL25407373

C#N.C#N.Cn1c(=O)n(C)c2cc(C=NN)c(Cl)cc21

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATAD2 Q6PL18 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.35
▸ HTT P42858 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ GAA P10253 1/20 0.35
▸ ALDH1A1 P00352 6/20 0.34
▸ HPGD P15428 4/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ CYP2C9 P11712 3/20 0.34
▸ CYP2C19 P33261 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ S100B P04271 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ BRPF1 P55201 2/20 0.33
▸ CCR4 P51679 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyanide SCHEMBL25408115 0.83 ATAD2 (0.49) ATAD2KDM4EHTTSMN1; SMN2GAA
Cyanide SCHEMBL25405305 0.82 PARG (0.38) ATAD2KDM4EHTTSMN1; SMN2GAA
Cyanide SCHEMBL25405783 0.79 S100B (0.53) KDM4EGAAALDH1A1HPGDKMT2A
Cyanide SCHEMBL25407204 0.77 MAOB (0.40) ATAD2KDM4EHTTSMN1; SMN2GAA
Cyanide SCHEMBL22130246 0.74 ALDH1A1 (0.57) KDM4EHTTSMN1; SMN2GAAALDH1A1
SCHEMBL30349855 0.68 ATAD2 (0.62) ATAD2KDM4EHTTSMN1; SMN2GAA
SCHEMBL14995348 0.68 ATAD2 (0.62) ATAD2KDM4EHTTSMN1; SMN2GAA
Cyanide SCHEMBL25405574 0.65 KDM4E (0.44) KDM4EHTTSMN1; SMN2GAAALDH1A1
Cyanide SCHEMBL25406481 0.65 S100B (0.42) KDM4EHTTSMN1; SMN2GAAALDH1A1
SCHEMBL19644300 0.64 ATAD2 (0.47) ATAD2KDM4EHTTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US claimed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP claimed
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT ATAD2 4077/4885KDM4E 2516/4885HTT 3351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback